InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...
Background Childhood interstitial lung disease (chILD) encompasses a group of rare heterogeneous respiratory conditions associated with significant morbidity and mortality. Reports suggest that many ...
Other known causes of neonatal respiratory distress were excluded with the exception of the occasional occurrence both of clinical hyaline-membrane disease and of pneumomediastinum. During the ...
To date, no other cases of tension pneumothorax with concomitant COVID-19 infection have been published, with one case of spontaneous pneumomediastinum reported by a team of Chinese clinicians.5 Of ...